$CLVS #Stocks #StockMarket #ClovisOncology reported Q1 EPS on https://t.co/savSNTKlN1: CLVS announced EPS per share of $-1.39 and Sales of $39 MM in the Q1, Company's decreased loss per share, versus $-1.63 eps, earned in the same quarter a year ago,… https://t.co/OCKuekH8Zs